-
Pexacerfont (INN,
previously known as BMS-562,086) is a drug
developed by Bristol-Myers
Squibb which acts as a CRF1 antagonist. Corticotropin-releasing...
-
stria terminalis compared to females. The CRH-1
receptor antagonist pexacerfont is
currently under investigation for the
treatment of
generalized anxiety...
-
poorly understood.
Corticotropin releasing hormone antagonists Antalarmin Pexacerfont Verucerfont Hubbard CS,
Labus JS,
Bueller J,
Stains J,
Suyenobu B, Dukes...
-
antagonist antalarmin and a
newer drug
pexacerfont. A
recent human trial disappointingly found that
pexacerfont did no
better than a
placebo in alleviating...
-
Corticotropin releasing hormone antagonists List of
investigational anxiolytics Pexacerfont Zorrilla EP,
Heilig M, de Wit H,
Shaham Y (March 2013). "Behavioral,...
-
Pertofrane pertuzumab (USAN)
perzinfotel (USAN)
pethidine (INN)
petrichloral (INN)
pexacerfont (USAN)
pexantel (INN)
pexelizumab (INN)
pexiganan (INN)...
-
investigation for the
potential treatment of alcoholism.
Antalarmin Pexacerfont Corticotropin releasing hormone antagonist Schulz DW,
Mansbach RS, Sprouse...
-
hormone receptor Corticotropin-releasing
hormone antagonist Antalarmin Pexacerfont Verucerfont GRCm38:
Ensembl release 89: ENSMUSG00000018634 – Ensembl...
- Astressin-B CP-154,526
Emicerfont Hypericin LWH-234 NBI-27914 NBI-74788
Pexacerfont R-121919 TS-041
Verucerfont Agonists Corticorelin Corticotropin-releasing...
- Astressin-B CP-154,526
Emicerfont Hypericin LWH-234 NBI-27914 NBI-74788
Pexacerfont R-121919 TS-041
Verucerfont Agonists:
Corticorelin Corticotropin-releasing...
